Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells

Table 1

Summary of the tyrosine kinase inhibitors and their effects on T315I.

TKI	Originally termed	TKI generation	Acts on T315I
Imatinib	STI571	First	No
Dasatinib	BMS-354825	Second	No
Nilotinib	AMN107	Second	No
Bosutinib	SKI-606	Second	No
Ponatinib	AP24534	Third	Yes